BridgeBio Oncology Therapeutics paid its one named executive on file $1.5M in FY2024 (Dec).
Pay of each named executive
Yong Ben, M.D., M.B.A.Chief Medical and Development Officer
| FY2024 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.